alexa A Case Report of Choroidal Metastasis from Renal Cell Carcinoma during Sunitinib Treatment: A Tumor Pharmacologic Sanctuary | Abstract
ISSN: 2165-7920

Journal of Clinical Case Reports
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report Open Access


Background: Choroidal metastasis from Renal Cell Carcinoma (RCC) is very rare and only one case during Sunitinib treatment has been published until now. Case presentation: In February 2015, a 61-year old, Caucasian man was hospitalized for acute dyspnea. In 2006, he underwent right nephrectomy for clear-cells RCC. Chest CT-scan showed multiple lung and lymph node metastases. Histological examination confirmed metastasis from clear-cells RCC. According to Motzer and Heng classification, the patient was classified as intermediate risk and, from March to July 2015, he received a total of 3 cycles of Sunitinib treatment. Despite a relevant tumor response in lung and lymph node metastases, he presented a brutally, unexplained, blurred vision in his right eye secondary to a choroidal metastasis. An external radiotherapy was administered without any relevant, clinical benefit. Considering tumor response in the other metastatic sites, Sunitinib treatment was continued and it is now ongoing. Conclusion: RCC-associated choroidal metastasis is extremely rare. In contrast with another case responding to Sunitinib therapy, our patient presented a significant tumor response to Sunitinib in the extraocular metastatic sites and a choroidal progression, suggesting that the choroid could be a potential tumor “pharmacologic sanctuary” for this drug. This case also raises the question of how to treat patients presenting an isolated disease progression in the sites which are very difficult to be reached by systemic treatment.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Raffaele Longo, Julie Egea, Natacha Naoun, Marco Campitiello, Christian Platini, Nada Eid, Laurent Hennequin, Jean-Marc Perone and Philippe Quétin


Choroidal metastasis, RCC, Sunitinib, Medical Case Reports

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version